Cytokinetics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 20.09 M | $1.71 B | 21.43% | 15.21% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 18.72 M | $1.59 B | 6.82% | 14.17% |
| STATE STREET CORP | 09/22/2026 | 6.49 M | $553.24 M | 13.04% | 5.27% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 6.93 M | $590.52 M | -13.46% | 5.25% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 6.71 M | $571.78 M | 14.85% | 5.08% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 6.12 M | $521.15 M | 11.46% | 4.63% |
| FMR LLC | 08/13/2026 | 5.03 M | $428.66 M | -53.08% | 3.81% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2026 | 5.00 M | $425.95 M | 50.00% | 3.79% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 4.64 M | $394.92 M | 48.32% | 3.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.71 M | $316.33 M | 15.46% | 2.81% |
| RTW INVESTMENTS, LP | 08/14/2026 | 2.86 M | $243.81 M | 5.18% | 2.17% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 2.25 M | $191.99 M | 35.66% | 1.71% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.96 M | $166.88 M | 23.65% | 1.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 1.89 M | $161.06 M | 90.05% | 1.43% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.76 M | $150.07 M | -20.14% | 1.33% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/12/2026 | 1.69 M | $143.68 M | 118.76% | 1.28% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.65 M | $140.34 M | 14.27% | 1.25% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 1.60 M | $136.60 M | 47.43% | 1.21% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2026 | 1.60 M | $136.30 M | 0.00% | 1.21% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.59 M | $139.15 M | 75.80% | 1.20% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 1.59 M | $135.26 M | 153.59% | 1.20% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.57 M | $133.39 M | 12.08% | 1.19% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.57 M | $133.39 M | 100.00% | 1.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 1.55 M | $132.00 M | 72.36% | 1.17% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 1.53 M | $130.34 M | -10.00% | 1.16% |
| MORGAN STANLEY | 08/13/2026 | 1.51 M | $128.66 M | 0.35% | 1.14% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 1.31 M | $111.74 M | 19.95% | 0.99% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 1.31 M | $111.25 M | -2.46% | 0.99% |
| INVESCO LTD. | 08/14/2026 | 1.24 M | $105.24 M | 154.72% | 0.94% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 1.20 M | $102.34 M | 57.13% | 0.91% |
| UBS GROUP AG | 08/13/2026 | 1.17 M | $99.78 M | -43.61% | 0.89% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 1.16 M | $99.04 M | 54.53% | 0.88% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 1.16 M | $98.81 M | 0.00% | 0.88% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 1.15 M | $98.03 M | 14.36% | 0.87% |
| HOLOCENE ADVISORS, LP | 08/14/2026 | 1.14 M | $97.51 M | 100.00% | 0.87% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.10 M | $93.77 M | 10.02% | 0.83% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.05 M | $89.29 M | 48.32% | 0.79% |
| NORGES BANK | 08/12/2026 | 1.02 M | $86.51 M | 100.00% | 0.77% |
| ROYALTY PHARMA SUB-MANAGER, LLC | 08/21/2026 | 980.39 K | $83.52 M | 0.00% | 0.74% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 961.82 K | $81.94 M | 1,883.82% | 0.73% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 916.11 K | $78.04 M | 85.21% | 0.69% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 906.42 K | $77.22 M | 13.36% | 0.69% |
| CITADEL ADVISORS LLC | 09/02/2026 | 904.60 K | $77.06 M | 520.86% | 0.68% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 891.09 K | $75.91 M | 117.45% | 0.67% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 827.81 K | $70.52 M | 15.88% | 0.63% |
| MELQART ASSET MANAGEMENT (UK) LTD | 08/14/2026 | 767.53 K | $65.39 M | -9.06% | 0.58% |
| SIREN, L.L.C. | 08/13/2026 | 758.95 K | $64.66 M | 23.62% | 0.57% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 743.70 K | $63.36 M | -3.20% | 0.56% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 08/14/2026 | 714.70 K | $60.88 M | 42.00% | 0.54% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 711.68 K | $60.63 M | -28.30% | 0.54% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytokinetics Inc institutional Ownership - FAQ's
During the previous two years, 639 institutional investors and hedge funds held shares of Cytokinetics Inc. The most heavily invested institutionals were:
Versant Capital Management, Inc: 114
ZRC WEALTH MANAGEMENT, LLC: 74
EASTERN BANK: 0
BlackRock, Inc.: 20.09 M
T. Rowe Price Investment Management, Inc.: 18.72 M
WELLINGTON MANAGEMENT GROUP LLP: 6.93 M
122.60% of Cytokinetics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 211.33 M shares in the last 24 months. This purchase volume represents approximately $13.19 B in transactions.